45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
24,435
Insurances with rates
21
CPT / HCPCS codes
4,029
Source MRF
Most expensive procedures (gross)
00078080461
$671,912
SandoSTATIN LAR Depot
Gross
$1,119,853
59572050300
$369,849
Pomalyst
Gross
$616,416
59572050400
$369,849
Pomalyst
Gross
$616,416
59572050100
$369,849
Pomalyst
Gross
$616,416
59572050200
$369,849
Pomalyst
Gross
$616,416
25682-0028-01
$228,250
Ultomiris
Gross
$380,416
00006306101
$162,643
Emend
Gross
$271,072
67457088910
$146,216
fosaprepitant dimeglumine
Gross
$243,694
71839010401
$146,216
fosaprepitant dimeglumine
Gross
$243,694
67457-0889-10
$146,216
fosaprepitant dimeglumine
Gross
$243,694
24338005008
$136,869
Gliadel
Gross
$228,115
00310453530
$134,105
Imjudo
Gross
$223,509
50242-0150-01
$127,749
Ocrevus
Gross
$212,915
00310-4535-30
$126,371
Imjudo
Gross
$210,619
60505267708
$122,618
ARIPiprazole
Gross
$204,364
58468-0426-01
$120,194
Nexviazyme
Gross
$200,323
00003232822
$117,360
Yervoy
Gross
$195,601
73150-0150-06
$108,000
Briumvi
Gross
$180,001
75987008010
$99,619
Krystexxa
Gross
$166,031
66215060214
$96,706
Uptravi
Gross
$161,176
51144-0050-01
$95,219
Adcetris
Gross
$158,699
57894006103
$94,462
Stelara PFS
Gross
$157,437
Q4116
$90,233
ALLODERM; PER SQUARE CENTIMETER
Gross
$150,388
C1822
$88,200
GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); HIGH FREQUENCY; WITH RECHARGEABLE BATTERY AND CHARGING SYS
Gross
$147,000
C1882
$88,200
CARDIOVERTER-DEFIBRILLATOR; OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$147,000
62935-0163-60
$84,693
Fensolvi
Gross
$141,155
C1826
$84,000
GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); INCLUDES CLOSED FEEDBACK LOOP LEADS AND ALL IMPLANTABLE CO
Gross
$140,000
59572041028
$80,893
Revlimid
Gross
$134,821
00187552675
$80,605
Targretin
Gross
$134,341
65597-0801-01
$79,247
Datroway
Gross
$132,078
00006508399
$77,974
Keytruda Qlex
Gross
$129,957
00006508301
$77,974
Keytruda Qlex
Gross
$129,957
59572050421
$77,677
Pomalyst
Gross
$129,462
25682002801
$77,612
Ultomiris
Gross
$129,354
75987-0080-10
$77,317
Krystexxa
Gross
$128,861
00069814120
$77,036
Xalkori
Gross
$128,393
00069814020
$77,036
Xalkori
Gross
$128,393
C1820
$76,881
GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON HIGH-FREQUENCY WITH RECHARGEABLE BATTERY AND CHARGING
Gross
$128,135
C1767
$76,545
GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON-RECHARGEABLE
Gross
$127,575
C2616
$75,579
BRACHYTHERAPY SOURCE; NON-STRANDED; YTTRIUM-90; PER SOURCE
Gross
$125,965
69488001061
$74,517
Pluvicto
Gross
$124,195
00069098038
$72,845
Sutent
Gross
$121,408
24338015020
$72,256
Triptodur
Gross
$120,426
J3316
$72,256
INJ., TRIPTORELIN XR 3.75 MG
Gross
$120,426
50242015001
$70,366
Ocrevus
Gross
$117,276
00069013501
$69,658
Bosulif
Gross
$116,096
00069013601
$69,657
Bosulif
Gross
$116,096
00078068715
$68,845
Promacta
Gross
$114,741
00069014501
$68,576
Inlyta
Gross
$114,294
00069015111
$68,576
Inlyta
Gross
$114,294
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 00078080461 | SandoSTATIN LAR Depot | $1,119,853 | $671,912 | — | — | 13 |
| 59572050300 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050400 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050100 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050200 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 25682-0028-01 | Ultomiris | $380,416 | $228,250 | — | — | 13 |
| 00006306101 | Emend | $271,072 | $162,643 | — | — | 1 |
| 67457088910 | fosaprepitant dimeglumine | $243,694 | $146,216 | — | — | 1 |
| 71839010401 | fosaprepitant dimeglumine | $243,694 | $146,216 | — | — | 1 |
| 67457-0889-10 | fosaprepitant dimeglumine | $243,694 | $146,216 | — | — | 1 |
| 24338005008 | Gliadel | $228,115 | $136,869 | — | — | 0 |
| 00310453530 | Imjudo | $223,509 | $134,105 | — | — | 13 |
| 50242-0150-01 | Ocrevus | $212,915 | $127,749 | — | — | 13 |
| 00310-4535-30 | Imjudo | $210,619 | $126,371 | — | — | 12 |
| 60505267708 | ARIPiprazole | $204,364 | $122,618 | — | — | 0 |
| 58468-0426-01 | Nexviazyme | $200,323 | $120,194 | — | — | 12 |
| 00003232822 | Yervoy | $195,601 | $117,360 | — | — | 13 |
| 73150-0150-06 | Briumvi | $180,001 | $108,000 | — | — | 12 |
| 75987008010 | Krystexxa | $166,031 | $99,619 | — | — | 13 |
| 66215060214 | Uptravi | $161,176 | $96,706 | — | — | 0 |
| 51144-0050-01 | Adcetris | $158,699 | $95,219 | — | — | 13 |
| 57894006103 | Stelara PFS | $157,437 | $94,462 | — | — | 1 |
| Q4116 | ALLODERM; PER SQUARE CENTIMETER | $150,388 | $90,233 | — | — | 17 |
| C1822 | GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); HIGH FREQUENCY; WITH RECHARGEABLE BATTERY AND CHARGING SYS | $147,000 | $88,200 | — | — | 0 |
| C1882 | CARDIOVERTER-DEFIBRILLATOR; OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $147,000 | $88,200 | — | — | 0 |
| 62935-0163-60 | Fensolvi | $141,155 | $84,693 | — | — | 12 |
| C1826 | GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); INCLUDES CLOSED FEEDBACK LOOP LEADS AND ALL IMPLANTABLE CO | $140,000 | $84,000 | — | — | 0 |
| 59572041028 | Revlimid | $134,821 | $80,893 | — | — | 0 |
| 00187552675 | Targretin | $134,341 | $80,605 | — | — | 0 |
| 65597-0801-01 | Datroway | $132,078 | $79,247 | — | — | 13 |
| 00006508399 | Keytruda Qlex | $129,957 | $77,974 | — | — | 0 |
| 00006508301 | Keytruda Qlex | $129,957 | $77,974 | — | — | 0 |
| 59572050421 | Pomalyst | $129,462 | $77,677 | — | — | 0 |
| 25682002801 | Ultomiris | $129,354 | $77,612 | — | — | 13 |
| 75987-0080-10 | Krystexxa | $128,861 | $77,317 | — | — | 12 |
| 00069814120 | Xalkori | $128,393 | $77,036 | — | — | 0 |
| 00069814020 | Xalkori | $128,393 | $77,036 | — | — | 0 |
| C1820 | GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON HIGH-FREQUENCY WITH RECHARGEABLE BATTERY AND CHARGING | $128,135 | $76,881 | — | — | 0 |
| C1767 | GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON-RECHARGEABLE | $127,575 | $76,545 | — | — | 2 |
| C2616 | BRACHYTHERAPY SOURCE; NON-STRANDED; YTTRIUM-90; PER SOURCE | $125,965 | $75,579 | — | — | 12 |
| 69488001061 | Pluvicto | $124,195 | $74,517 | — | — | 13 |
| 00069098038 | Sutent | $121,408 | $72,845 | — | — | 0 |
| 24338015020 | Triptodur | $120,426 | $72,256 | — | — | 13 |
| J3316 | INJ., TRIPTORELIN XR 3.75 MG | $120,426 | $72,256 | — | — | 13 |
| 50242015001 | Ocrevus | $117,276 | $70,366 | — | — | 13 |
| 00069013501 | Bosulif | $116,096 | $69,658 | — | — | 0 |
| 00069013601 | Bosulif | $116,096 | $69,657 | — | — | 0 |
| 00078068715 | Promacta | $114,741 | $68,845 | — | — | 0 |
| 00069014501 | Inlyta | $114,294 | $68,576 | — | — | 0 |
| 00069015111 | Inlyta | $114,294 | $68,576 | — | — | 0 |
Showing top 50 of 24,435 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.